Promoters held 59.45 per cent stake in the company as of 31-Dec-2022, while FIIs owned 22.6 per cent, DIIs 10.27 per cent.

Havells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 75140.45 Crore) operating in Consumer Durab...

Buying demand emerging from the rising demand line joining last onemonths lows and 50 days EMA signalling strength.

Nevertheless, it slashes earnings estimates to factor in muted consumer demand and subdued 9MFY23 performance.

Havells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 71970.11 Crore) operating in Consumer Durab...

Havells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 72524.57 Crore) operating in Consumer Durab...

Malik is in Tihar Jail in judicial custody in two cases, including one related to terror funding.

A study presented two months back had also concluded that another Indian stent, Supra Flex was as good as Xience.

The study dispels the perception among many doctors and patients that stents made in India may not be as safe and efficacious as those manu...

Almost 64.9% of 314 individuals who were assessed during a camp were found either over-weight or obese, which are important risk factors fo...

At the same time, Indian firms upped their share of the market to 61% in 2017 from 57% in 2016 after marginally increasing their distributi...

The company will test the quality, safety and efficacy of 86 variations of Supraflex stents against their Xience equivalents between now an...

The process may require the drug pricing watchdog to look at a set of separate parameters for these devices as compared to that for drugs.

There are several combination tablets which can be taken early morning before the start of fasting and after breaking the fast.

As per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...

Ranbaxy Laboratories is seeing some people movement with three senior executives leaving and its former HR head rejoining the company.

After successful clinical studies in Europe, a new generation of drug-coated stents have been introduced for the first time in India at the...